D63N (p.Asp63Asn) variant of SLC35A2 (UDP-galactose translocator)

D63N (p.Asp63Asn) in SLC35A2 (UDP-galactose translocator) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely benign in the context of SLC35A2-congenital disorder of glycosylation. The available variant effect predictions contribute to a CATVariant prioritization score of 0.36 / 1. The record also includes structural context.

D63N (p.Asp63Asn) variant details